Home / Health / Superbugs Threaten ICU Care: Antibiotic Resistance Soars
Superbugs Threaten ICU Care: Antibiotic Resistance Soars
20 Apr
Summary
- Gram-negative bacteria show high resistance to antibiotics.
- Carbapenem resistance nears 70%, limiting treatment options.
- ICUs are epicenters for infections due to vulnerability.

A hospital-based cross-sectional study published in March 2026 highlights a critical rise in antimicrobial resistance among gram-negative pathogens isolated from intensive care unit (ICU) blood cultures. Researchers analyzed 247 bacterial isolates collected between January 2023 and December 2024, revealing widespread resistance to multiple antibiotic classes.
Klebsiella pneumoniae was the most prevalent pathogen, accounting for 27.5% of isolates, followed by Escherichia coli at 20.6%. These bacteria demonstrated resistance to penicillins, cephalosporins, and even carbapenems, with resistance to meropenem approaching 70%. Notably, nearly 78% of Klebsiella pneumoniae isolates were resistant to ceftazidime-avibactam, a concerning trend indicating dwindling treatment options even with advanced drugs.